Logo image of LFST

LIFESTANCE HEALTH GROUP INC (LFST) Stock Fundamental Analysis

USA - NASDAQ:LFST - US53228F1012 - Common Stock

5.28 USD
+0.05 (+0.96%)
Last: 9/22/2025, 12:58:09 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LFST. LFST was compared to 101 industry peers in the Health Care Providers & Services industry. The financial health of LFST is average, but there are quite some concerns on its profitability. While showing a medium growth rate, LFST is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LFST had negative earnings in the past year.
LFST had a positive operating cash flow in the past year.
LFST had negative earnings in each of the past 5 years.
In multiple years LFST reported negative operating cash flow during the last 5 years.
LFST Yearly Net Income VS EBIT VS OCF VS FCFLFST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

LFST has a Return On Assets of -0.75%. This is comparable to the rest of the industry: LFST outperforms 45.54% of its industry peers.
LFST has a Return On Equity (-1.10%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.75%
ROE -1.1%
ROIC N/A
ROA(3y)-7.15%
ROA(5y)-11.83%
ROE(3y)-10.4%
ROE(5y)-16.72%
ROIC(3y)N/A
ROIC(5y)N/A
LFST Yearly ROA, ROE, ROICLFST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

LFST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LFST Yearly Profit, Operating, Gross MarginsLFST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

More info and screens

5

2. Health

2.1 Basic Checks

LFST does not have a ROIC to compare to the WACC, probably because it is not profitable.
LFST has more shares outstanding than it did 1 year ago.
The number of shares outstanding for LFST has been increased compared to 5 years ago.
LFST has a worse debt/assets ratio than last year.
LFST Yearly Shares OutstandingLFST Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
LFST Yearly Total Debt VS Total AssetsLFST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

LFST has an Altman-Z score of 1.96. This is not the best score and indicates that LFST is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.96, LFST is in line with its industry, outperforming 46.53% of the companies in the same industry.
The Debt to FCF ratio of LFST is 2.36, which is a good value as it means it would take LFST, 2.36 years of fcf income to pay off all of its debts.
LFST's Debt to FCF ratio of 2.36 is amongst the best of the industry. LFST outperforms 82.18% of its industry peers.
LFST has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
LFST has a Debt to Equity ratio of 0.19. This is in the better half of the industry: LFST outperforms 70.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 2.36
Altman-Z 1.96
ROIC/WACCN/A
WACC8.89%
LFST Yearly LT Debt VS Equity VS FCFLFST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.48 indicates that LFST should not have too much problems paying its short term obligations.
LFST has a Current ratio (1.48) which is comparable to the rest of the industry.
A Quick Ratio of 1.48 indicates that LFST should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.48, LFST is in line with its industry, outperforming 54.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48
LFST Yearly Current Assets VS Current LiabilitesLFST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.80% over the past year.
The Revenue has grown by 13.86% in the past year. This is quite good.
The Revenue has been growing by 42.55% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)87.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.33%
Revenue 1Y (TTM)13.86%
Revenue growth 3Y23.29%
Revenue growth 5Y42.55%
Sales Q2Q%10.56%

3.2 Future

Based on estimates for the next years, LFST will show a very strong growth in Earnings Per Share. The EPS will grow by 46.75% on average per year.
The Revenue is expected to grow by 12.39% on average over the next years. This is quite good.
EPS Next Y84.86%
EPS Next 2Y51.34%
EPS Next 3Y46.75%
EPS Next 5YN/A
Revenue Next Year14.17%
Revenue Next 2Y14.23%
Revenue Next 3Y14.52%
Revenue Next 5Y12.39%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LFST Yearly Revenue VS EstimatesLFST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
LFST Yearly EPS VS EstimatesLFST Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LFST. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 113.62 indicates a quite expensive valuation of LFST.
Based on the Price/Forward Earnings ratio, LFST is valued a bit more expensive than the industry average as 61.39% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 22.86. LFST is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 113.62
LFST Price Earnings VS Forward Price EarningsLFST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100 -100

4.2 Price Multiples

LFST's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LFST indicates a somewhat cheap valuation: LFST is cheaper than 71.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.1
EV/EBITDA 37.04
LFST Per share dataLFST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LFST's earnings are expected to grow with 46.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.34%
EPS Next 3Y46.75%

More info and screens

0

5. Dividend

5.1 Amount

LFST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIFESTANCE HEALTH GROUP INC

NASDAQ:LFST (9/22/2025, 12:58:09 PM)

5.28

+0.05 (+0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners36.59%
Inst Owner Change1.58%
Ins Owners2.98%
Ins Owner Change-8.61%
Market Cap2.05B
Analysts84
Price Target8.6 (62.88%)
Short Float %4.95%
Short Ratio2.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)83.66%
Min EPS beat(2)67.32%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)70.6%
Min EPS beat(4)43.98%
Max EPS beat(4)100%
EPS beat(8)6
Avg EPS beat(8)24.17%
EPS beat(12)9
Avg EPS beat(12)15.58%
EPS beat(16)9
Avg EPS beat(16)3.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.94%
Min Revenue beat(2)-1.94%
Max Revenue beat(2)-1.93%
Revenue beat(4)2
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)1.72%
Revenue beat(8)4
Avg Revenue beat(8)0.36%
Revenue beat(12)6
Avg Revenue beat(12)0.34%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)1.4%
PT rev (3m)-3.28%
EPS NQ rev (1m)16.7%
EPS NQ rev (3m)16.7%
EPS NY rev (1m)0%
EPS NY rev (3m)51.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 113.62
P/S 1.56
P/FCF 17.1
P/OCF 14.01
P/B 1.39
P/tB N/A
EV/EBITDA 37.04
EPS(TTM)-0.05
EYN/A
EPS(NY)0.05
Fwd EY0.88%
FCF(TTM)0.31
FCFY5.85%
OCF(TTM)0.38
OCFY7.14%
SpS3.38
BVpS3.79
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.75%
ROE -1.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 9.12%
ROA(3y)-7.15%
ROA(5y)-11.83%
ROE(3y)-10.4%
ROE(5y)-16.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 2.36
Debt/EBITDA 4.75
Cap/Depr 45.9%
Cap/Sales 2.01%
Interest Coverage N/A
Cash Conversion 255.02%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z 1.96
F-Score7
WACC8.89%
ROIC/WACCN/A
Cap/Depr(3y)65.1%
Cap/Depr(5y)98.49%
Cap/Sales(3y)4.93%
Cap/Sales(5y)7.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.33%
EPS Next Y84.86%
EPS Next 2Y51.34%
EPS Next 3Y46.75%
EPS Next 5YN/A
Revenue 1Y (TTM)13.86%
Revenue growth 3Y23.29%
Revenue growth 5Y42.55%
Sales Q2Q%10.56%
Revenue Next Year14.17%
Revenue Next 2Y14.23%
Revenue Next 3Y14.52%
Revenue Next 5Y12.39%
EBIT growth 1Y99.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year426.23%
EBIT Next 3Y94.79%
EBIT Next 5YN/A
FCF growth 1Y1147.77%
FCF growth 3YN/A
FCF growth 5Y99.09%
OCF growth 1Y339.74%
OCF growth 3Y124.97%
OCF growth 5Y44.46%